News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
HENGRUI PHARMA, BMS Clinch Global Strategic Collaboration and License Agreement
HENGRUI PHARMA (01276.HK) announced that it had entered into global strategic collaboration and license agreements with Bristol-Myers Squibb Company (BMS)(BMY.US) to advance a port...
Reset
Send
The window will close in 5 seconds
HENGRUI PHARMA, BMS Clinch Global Strategic Collaboration and License Agreement
Close
Recommend
11
Positive
8
Negative
8
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get Level 1 Real-Time Streaming!

HENGRUI PHARMA (01276.HK)  0.000 (0.000%)    Short selling $61.84M; Ratio 22.448%   announced that it had entered into global strategic collaboration and license agreements with Bristol-Myers Squibb Company (BMS)(BMY.US)      to advance a portfolio of 13 early stage programs in oncology, hematology and immunology.

Under the agreement, BMS will pay HENGRUI PHARMA up to USD950 million, including a USD600 million upfront payment, a USD175 million first anniversary payment, and a second contingent anniversary payment of USD175 million in 2028.

Related News Citi Cuts HSI 2026 TP to 29,600; TENCENT (00700.HK), AIA (01299.HK) Among Top H Shrs Picks
The potential total value of the agreements is up to approximately USD15.2 billion, including the exercise of available options for the joint discovery programs and the achievement of applicable development, regulatory, and commercial milestones for all programs.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-14 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.